Blue Owl Capital Holdings’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Buy |
4,928,040
+150,000
| +3% | +$434K | 4.6% | 6 |
|
|
2025
Q1 | $10.3M | Buy |
4,778,040
+125,000
| +3% | +$269K | 3.31% | 9 |
|
|
2024
Q4 | $18M | Buy |
4,653,040
+486,211
| +12% | +$1.88M | 4.15% | 10 |
|
|
2024
Q3 | $27.3M | Buy |
4,166,829
+307,361
| +8% | +$2.01M | 5.26% | 7 |
|
|
2024
Q2 | $28M | Sell |
3,859,468
-135,000
| -3% | -$979K | 7.78% | 5 |
|
|
2024
Q1 | $30.3M | Buy |
3,994,468
+580,000
| +17% | +$4.4M | 6.06% | 8 |
|
|
2023
Q4 | $15.5M | Buy |
+3,414,468
| New | +$15.5M | 3.71% | 9 |
|